TELLURIAN INC (TELL)

US87968A1043 - Common Stock

0.679  +0.09 (+14.37%)

Fundamental Rating

2

Taking everything into account, TELL scores 2 out of 10 in our fundamental rating. TELL was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. TELL may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, TELL is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year TELL has reported negative net income.
TELL had a negative operating cash flow in the past year.
TELL had negative earnings in each of the past 5 years.
TELL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

TELL's Return On Assets of -12.55% is on the low side compared to the rest of the industry. TELL is outperformed by 93.90% of its industry peers.
With a Return On Equity value of -26.59%, TELL is not doing good in the industry: 90.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -12.55%
ROE -26.59%
ROIC N/A
ROA(3y)-11.5%
ROA(5y)-29.22%
ROE(3y)-20.48%
ROE(5y)-69.16%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TELL has a Gross Margin (52.54%) which is in line with its industry peers.
In the last couple of years the Gross Margin of TELL has grown nicely.
The Profit Margin and Operating Margin are not available for TELL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.24%
GM growth 5Y5.33%

1

2. Health

2.1 Basic Checks

TELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TELL has more shares outstanding
Compared to 5 years ago, TELL has more shares outstanding
Compared to 1 year ago, TELL has an improved debt to assets ratio.

2.2 Solvency

TELL has an Altman-Z score of -1.12. This is a bad value and indicates that TELL is not financially healthy and even has some risk of bankruptcy.
TELL's Altman-Z score of -1.12 is on the low side compared to the rest of the industry. TELL is outperformed by 73.71% of its industry peers.
TELL has a Debt/Equity ratio of 0.77. This is a neutral value indicating TELL is somewhat dependend on debt financing.
TELL's Debt to Equity ratio of 0.77 is on the low side compared to the rest of the industry. TELL is outperformed by 63.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACC5.62%

2.3 Liquidity

TELL has a Current Ratio of 0.66. This is a bad value and indicates that TELL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.66, TELL is doing worse than 83.10% of the companies in the same industry.
TELL has a Quick Ratio of 0.66. This is a bad value and indicates that TELL is not financially healthy enough and could expect problems in meeting its short term obligations.
TELL has a Quick ratio of 0.66. This is in the lower half of the industry: TELL underperforms 78.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66

5

3. Growth

3.1 Past

The earnings per share for TELL have decreased strongly by -172.73% in the last year.
Looking at the last year, TELL shows a very negative growth in Revenue. The Revenue has decreased by -57.61% in the last year.
Measured over the past years, TELL shows a very strong growth in Revenue. The Revenue has been growing by 74.42% on average per year.
EPS 1Y (TTM)-172.73%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-133.33%
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y64.34%
Revenue growth 5Y74.42%
Revenue growth Q2Q-61.03%

3.2 Future

Based on estimates for the next years, TELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.27% on average per year.
TELL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 74.17% yearly.
EPS Next Y37.1%
EPS Next 2Y24.14%
EPS Next 3Y19.21%
EPS Next 5Y9.27%
Revenue Next Year-30.92%
Revenue Next 2Y1.94%
Revenue Next 3Y9.91%
Revenue Next 5Y74.17%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

0

4. Valuation

4.1 Price/Earnings Ratio

TELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TELL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

TELL's earnings are expected to grow with 19.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.14%
EPS Next 3Y19.21%

0

5. Dividend

5.1 Amount

No dividends for TELL!.
Industry RankSector Rank
Dividend Yield N/A

TELLURIAN INC

NYSEARCA:TELL (3/28/2024, 12:08:08 PM)

0.679

+0.09 (+14.37%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap531.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.55%
ROE -26.59%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 52.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-172.73%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y37.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y64.34%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y